Medication info
Simvastatin 20 mg Tablets

Simvastatin 20 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
Ajou Pharmaceutical Co., Ltd.
Appearance
Yellowish-brown oval film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 200400724 · Notified 2004.05.29 · Insurance code 654000580

Summary

Main use
Improvement of hyperlipidemia and pediatric familial hypercholesterolemia; prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. 1. Reduction of the risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended starting dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended starting dose is 20 mg of this drug once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this drug. A dose of 5 ~ 40 mg of this drug once daily in the evening is recommended. Adjust the dose appropriately according to the baseline LDL cholesterol level before starting treatment, the treatment target, and the patient's response to the drug. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of this drug at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) See below for the recommended doses in patients receiving this drug concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on controlled clinical trial results, patients with homozygous familial hypercholesterolemia should receive 40 mg of this drug once daily in the evening. This drug may be administered concomitantly with other lipid-lowering therapies (e.g., LDL apheresis), or when other lipid-lowering therapies are not available. (2) In elderly patients, the maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this drug. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this drug is administered concomitantly to patients receiving verapamil, diltiazem, or dronedarone, the dose of this drug should not exceed 10 mg per day. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this drug is administered concomitantly to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this drug should not exceed 20 mg per day. (5) Concomitant use with other lipid-lowering drugs This drug is effective when administered alone or concomitantly with a bile acid sequestrant. When this drug is administered concomitantly with a fibrate (excluding gemfibrozil (see 2. Patients in Whom the Drug Is Contraindicated under Precautions for Use) and fenofibrate), the dose of this drug should not exceed 10 mg per day. (6) Use in patients with renal impairment Because this drug is not extensively excreted by the kidneys, dosage adjustment is not required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, the initial dose should be 5 mg per day, and the patient should be monitored closely.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily, administered in the evening. The recommended dosage range is 10 ~ 40 mg once daily, and the recommended maximum dose is 40 mg once daily. The dose should be adjusted appropriately for each patient according to the recommended treatment goals. Dose adjustments should be made at intervals of 4 weeks or more.

Ingredients

Manufacturer
Ajou Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia and pediatric familial hypercholesterolemia; prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • other cerebrovascular diseases
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medication is used to reduce the risk of cardiovascular diseases. It decreases the risk of death and non-fatal myocardial infarction and stroke due to coronary heart disease in adult patients with a history of various cardiovascular diseases including coronary heart disease, diabetes, peripheral vascular disease, and stroke. It also reduces the risks after coronary and non-coronary vascular surgery, thereby protecting cardiovascular health. It is effective in the treatment of hyperlipidemia, helping to lower cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia. Particularly, it is effective as an adjunct to diet therapy in pediatric patients with heterozygous familial hypercholesterolemia, reducing total cholesterol and LDL cholesterol levels. Therefore, it is widely used to improve cardiovascular diseases and dyslipidemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. 1. Reduction of the risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended starting dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended starting dose is 20 mg of this drug once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this drug. A dose of 5 ~ 40 mg of this drug once daily in the evening is recommended. Adjust the dose appropriately according to the baseline LDL cholesterol level before starting treatment, the treatment target, and the patient's response to the drug. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of this drug at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) See below for the recommended doses in patients receiving this drug concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on controlled clinical trial results, patients with homozygous familial hypercholesterolemia should receive 40 mg of this drug once daily in the evening. This drug may be administered concomitantly with other lipid-lowering therapies (e.g., LDL apheresis), or when other lipid-lowering therapies are not available. (2) In elderly patients, the maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this drug. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this drug is administered concomitantly to patients receiving verapamil, diltiazem, or dronedarone, the dose of this drug should not exceed 10 mg per day. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this drug is administered concomitantly to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this drug should not exceed 20 mg per day. (5) Concomitant use with other lipid-lowering drugs This drug is effective when administered alone or concomitantly with a bile acid sequestrant. When this drug is administered concomitantly with a fibrate (excluding gemfibrozil (see 2. Patients in Whom the Drug Is Contraindicated under Precautions for Use) and fenofibrate), the dose of this drug should not exceed 10 mg per day. (6) Use in patients with renal impairment Because this drug is not extensively excreted by the kidneys, dosage adjustment is not required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, the initial dose should be 5 mg per day, and the patient should be monitored closely.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily, administered in the evening. The recommended dosage range is 10 ~ 40 mg once daily, and the recommended maximum dose is 40 mg once daily. The dose should be adjusted appropriately for each patient according to the recommended treatment goals. Dose adjustments should be made at intervals of 4 weeks or more.

Precautions

This medication carries a risk of muscle problems, so if muscle pain or weakness occurs, especially when taking a high dose, inform your doctor immediately. This medication may affect liver function, so patients with liver disease or abnormal liver function tests should not take it. Pregnant women, women who may become pregnant, and nursing mothers should not take this medication. If taken with certain other medications, the risk of muscle damage may increase, so it is essential to inform your doctor or pharmacist if you are taking other medications. Excessive alcohol consumption or a history of liver or kidney disease requires careful use of this medication, and regular monitoring may be necessary. Elderly patients and women are at a higher risk of developing muscle problems, so caution is needed. It is advisable to regularly check liver function and muscle condition while taking this medication. Some patients may experience side effects such as headaches, dyspepsia, constipation, nausea, or other symptoms, and if symptoms persist, consult your doctor. It is recommended to avoid taking this medication with grapefruit juice, as grapefruit juice can increase the drug’s blood concentration and the risk of side effects. Avoid taking this medication during pregnancy or nursing, and women planning to become pregnant should consult their doctor before taking it. Inform your doctor if you are starting any new medications while taking this drug. In case of overdose, seek medical attention immediately for appropriate treatment. This medication should be kept out of reach of children and stored in its original container for safety.

Side effects

  • myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 88 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • taste disturbance
  • ophthalmoplegia
  • facial paresis
  • tremor
  • sensory disturbance
  • peripheral neuropathy
  • peripheral nerve palsy
  • mental disorder
  • anxiety
  • sleep disorder
  • nightmares
  • depression
  • cognitive impairment
  • severe muscular weakness
  • ocular myasthenia
  • hepatitis
  • jaundice
  • liver dysfunction
  • pancreatitis
  • liver failure
  • cholestatic jaundice
  • hepatic steatosis
  • liver cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • loss of appetite
  • vomiting
  • alopecia
  • pruritus
  • skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • cataract progression
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GTP
  • increased bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus erythematosus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • lethargy
  • dyspnea
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • erythema multiforme
  • sensory numbness in limbs
  • tingling
  • cold sensation
  • muscle weakness
  • thrombocytopenia
  • interstitial lung disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. This way, the drug's effectiveness and safety can be well preserved.

Appearance and packaging

Appearance

Yellowish-brown oval film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.